Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00186056 · ClinicalTrials.gov registry record · NA
Mifepristone in Refractory Depression
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 31
- Enrollment target
NCT00186056 is a NA study that has completed, run by Stanford University. The registered enrollment target is 31 participants.
The verdict
NCT00186056, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 31 participants
- Enrollment target
Study Summary
The purpose of the study is to examine the effectiveness of mifepristone treatment in patients with refractory depression. Refractory depression is defined as clinical depression that is unimproved after treatment with at least 2 different antidepressants of adequate dose and time trial. Mifepristone will augment current medications.
Interventions
- DRUG Mifepristone
- DRUG Placebo Oral Tablet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2003-01 |
| Est. Completion | 2007-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00186056
The ClinicalTrials.gov registry entry for NCT00186056 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Mifepristone is the first listed.
NCT00186056 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00186056 about?
NCT00186056 is a clinical study titled "Mifepristone in Refractory Depression". The purpose of the study is to examine the effectiveness of mifepristone treatment in patients with refractory depression. Refractory depression is defined as clinical depression that is unimproved after treatment with at least 2 different antidepressants of adequate dose and time trial. Mifepriston...
What is the current status of trial NCT00186056?
This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2003-01. Estimated completion is 2007-05.
What interventions are being tested in trial NCT00186056?
The interventions under investigation include: Mifepristone (DRUG), Placebo Oral Tablet (DRUG).
Who is sponsoring clinical trial NCT00186056?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.